AKUMSDRUGSPHARMACEUTICAL / Q4-FY26 / claim-ledger

Audit the questions that mattered.

Akums Drugs & · Analyst questions, management answers, and the quality of the response where the ledger is available.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

PositiveQ4-FY26 · 2026-05-15Back to quarter ↗

Questions audited

Answered directly

59%

Numeric claims

Consistency

contradicted

Question ledger

What was answered, and how?

Sil Kapoor · Antifragile Thinking

partial

Which internal capabilities are least scalable for regulated market ramp-up?

we already serve large Indian customers and MNC's Indian markets who themselves have a strict K sheet... we received the first European GMP approval way back in 22... plan 3 also received an visa approval this year

Sil Kapoor · Antifragile Thinking

evasive

What is net effect on gross margin from negative and positive loops?

as a business model it's a pass through business model. So whatever is the cost of input material gets passed on as part of a CDMO contracts... we have been investing over 100 crores in our R&D... we can gradually move up our gross margins.

Adja Sher · Incred Asset Management

partial

What drives volume variance >25% and will price variance reverse?

this is primarily led from existing customers only... increased demand for existing brands... similar double digit growth is also visible as we sit in May for the Q1... API prices have slightly gone up single high digits

Adja Sher · Incred Asset Management

partial

Outlook for trade generics and API business, and tax rate for FY27?

trade genic... is expected to remain at similar levels of revenue with similar levels of aida... API... we are hopeful we should do much better... tax rate... 29 on phone and overall is something we can build into our business models

Pravin Jaman · Aventus Park

direct

Why did CDMO margins expand to 14.4% despite adverse product mix?

Q4 of 25 was an year where we had significant dip in aa driven again by the product portfolio and some year end provisions... in Q4 we had less of those low margin product and hence this looks to be an regular quarter.

Pravin Jaman · Aventus Park

declined

Has Schedule M implementation improved visibility or customer inquiries?

I will like to skip this question because honestly we have no visibility on ground of how the government plans to roll this out.

Ankurkumar · Alpha Capital

partial

What overall CDMO revenue growth and margins expected this year?

we have visibility for 45 to 60 days of our revenue book... we expect a double digit volume growth right so while H2 still has to be seen... Similar margin profile what we currently have?

Rohit Banani · Vij Global

direct

Purpose of land lease deed in Haridwar and expansion plans?

this is simply one of those activities we will need for expansion of our capacities as well as building utility supports and so on.

Rohit Banani · Vij Global

direct

Expected annual revenue from European contract of 200 million euros?

once we start we will have almost a 35 million euro on a matt basis... 35 for the next 6 years till 2032.

Achel Mahishwari · Razer Investments

direct

Why did international branded business revenue decline but margins improve to 28%?

we are focusing on marketing of brands rather than just pure B2B play... also we got some benefits of the US so since it's USD we got some benefits from the forex gain... gross margins to be up by over 3 and a half 4%.

Dia · Safar Capital

direct

What was capex for FY26 and target for this year?

FYI26 we did a capex of 222 crores and this year we are targeting to keep our capex to a 300 crores.

Nitesh · Christ Capital

partial

Will CDMO margins improve to 15-16% with new contracts?

We can think through that the base margins for the business once both of these contracts are in full swing will improve.